GBI Research


Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need

Published: Jan-2013    Report Code: GBIHC293MR    Report Format: Electronic PDF
GBI Research, the leading business intelligence provider, has released its latest research: “Inherited Orphan Blood Disorders Therapeutics Market to 2019 – Breakthrough Drugs Remain Elusive against Backdrop of High Unmet Need”. The report provides insights into the up-and-coming trends of a portion of the inherited orphan blood disorder pharmaceutical market by examining sickle cell anemia, thalassemia and Hereditary Angioedema (HAE) in seven major markets: the US, the top five European countries (France, Germany, Italy, Spain and the UK) and Japan. The report includes market forecasts to 2019, detailed pipeline analysis, in-depth profiling of major products and details of recent industry deals. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts. The sickle cell anemia market will be the fastest growing of the three markets during the forecast period with a Compound Annual Growth Rate (CAGR) of 9% seeing it reach $70m in 2019. The thalassemia market will grow at a lower CAGR of 7% to reach $59m in 2019. HAE represents the largest but slowest growing market, expected to reach $1.89 billion by 2019 at a CAGR of 3%.


  • Current and future treatment trends for three rare diseases
  • Market forecasts for three rare diseases across seven major markets
  • Analysis of the developmental pipelines for three rare diseases
  • Information on recent industry deals

Reasons to Buy

  • Understand how the inherited orphan blood diseases market has developed and is continuing to develop within the featured markets
  • Predict which products are likely to be most successful in the future
  • Gain an understanding of the possible market available for specific products

License Details

Single User License: 
Buy Now Add to Cart
Site License: 
Buy Now Add to Cart
Global License: 
Buy Now Add to Cart